BB Biotech AG

  • Market Cap: N/A
  • Industry: Finance
  • ISIN: CH0038389992
CHF
42.85
-0.45 (-1.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
76.81
62.13
-17.26
-28.35
307.66
280.93
240.87
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
76.81
62.13
-17.26
-28.35
307.66
280.93
240.87
Raw Material Cost
0.06
4.98
5.80
1.73
0.99
0.88
1.24
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.77
0.75
0.72
0.70
0.63
0.72
0.77
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.44
0.49
0.45
0.52
0.64
0.55
0.58
Selling and Distribution Expenses
27.34
28.93
32.26
40.49
56.56
47.38
47.45
Other Expenses
-53.86
-4.95
14.96
28.55
65.29
-46.23
-48.84
Total Expenditure (Excl Depreciation)
-510.02
-14.31
188.82
328.88
711.76
-412.73
-438.38
Operating Profit (PBDIT) excl Other Income
586.8
76.39999999999999
-206.1
-357.2
-404.09999999999997
693.7
679.2
Other Income
-8.19
0.00
0.00
0.00
0.00
-1.86
-1.17
Operating Profit (PBDIT)
578.64
76.44
-206.08
-357.24
-404.10
691.80
678.08
Interest
0.44
0.49
0.45
0.52
0.64
0.55
0.58
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
76.76
57.16
-23.07
-30.08
306.67
280.05
239.63
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
578.20
75.95
-206.53
-357.75
-404.74
691.25
677.50
Tax
0.07
0.05
0.08
0.06
0.07
0.07
0.07
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
578.13
75.90
-206.61
-357.81
-404.81
691.17
677.43
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
578.13
75.90
-206.61
-357.81
-404.81
691.17
677.43
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
578.13
75.90
-206.61
-357.81
-404.81
691.17
677.43
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.2
0.2
0.2
0.2
0.2
0.2
0.2
Reserves
2,778.78
2,286.29
2,323.22
2,686.14
3,283.49
3,887.55
3,392.97
Earnings per share (EPS)
10.54
1.38
-3.77
-6.5
-7.31
12.48
12.23
Diluted Earnings per share
10.54
1.38
-3.77
-6.5
-7.31
12.48
12.23
Operating Profit Margin (Excl OI)
763.99%
123.03%
0.0%
0.0%
-131.35%
246.92%
282.0%
Gross Profit Margin
752.75%
122.24%
1196.29%
1261.91%
-131.55%
246.06%
281.27%
PAT Margin
752.66%
122.16%
0.0%
0.0%
-131.58%
246.03%
281.24%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 23.67% vs 458.96% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 661.66% vs 136.74% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 668.06% vs 137.07% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -20.00% vs 25.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of BB Biotech AG With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CHF)
Change(%)
Net Sales
76.81
112.51
-35.70
-31.73%
Other Operating Income
0.00
0.00
0.00
Total Operating income
76.81
112.51
-35.70
-31.73%
Raw Material Cost
0.06
53.79
-53.73
-99.89%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.77
0.00
0.77
Power Cost
0
0
0.00
Manufacturing Expenses
0.44
20.12
-19.68
-97.81%
Selling and Distribution Expenses
27.34
267.02
-239.68
-89.76%
Other Expenses
-53.86
11.51
-65.37
-567.94%
Total Expenditure (Excl Depreciation)
-510.02
456.00
-966.02
-211.85%
Operating Profit (PBDIT) excl Other Income
586.83
-343.49
930.32
270.84%
Other Income
-8.19
126.38
-134.57
-106.48%
Operating Profit (PBDIT)
578.64
-199.25
777.89
390.41%
Interest
0.44
20.12
-19.68
-97.81%
Exceptional Items
0.00
-26.09
26.09
100.00%
Gross Profit (PBDT)
76.76
58.72
18.04
30.72%
Depreciation
0.00
17.87
-17.87
-100.00%
Profit Before Tax
578.20
-263.32
841.52
319.58%
Tax
0.07
0.43
-0.36
-83.72%
Provisions and contingencies
0
0
0.00
Profit After Tax
578.13
-263.76
841.89
319.19%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
578.13
-263.76
841.89
319.19%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
578.13
-263.76
841.89
319.19%
Equity Capital
0
0
0.00
Face Value
0.20
0.05
0.00
Reserves
2,778.78
-1,212.14
3,990.92
329.25%
Earnings per share (EPS)
10.54
-1.45
11.99
826.90%
Diluted Earnings per share
10.54
-1.45
11.99
826.90%
Operating Profit Margin (Excl OI)
763.99%
-305.30%
0.00
1,069.29%
Gross Profit Margin
752.75%
-218.17%
0.00
970.92%
PAT Margin
752.66%
-234.43%
0.00
987.09%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 7.68 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 23.67% vs 458.96% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 57.81 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 661.66% vs 136.74% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 58.68 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 668.06% vs 137.07% in Dec 2024

Annual - Interest
Interest 0.04 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -20.00% vs 25.00% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 763.99%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024